Polycystic Kidney Diseases Clinical Trial
Official title:
Study and Management of Cystic Complications in Autosomal Dominant Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease is characterised by the development of renal and hepatic cysts. While the main complication is chronic end-stage renal failure, specific cyst-related complications are common: intracystic haemorrhage, renal or hepatic cyst infections, cyst-related mechanical complications and lithiasis. To date, there is no reliable epidemiological data on the frequency and clinical impact of these complications. Diagnosis of these complications is often complicated, and their management has not been codified. The latest international recommendations (KDIGO) provide only low-level recommendations. For the most complex cases (recurrent cystic infections, resistant pain, mechanical complications and malnutrition, need for pre-transplant nephrectomy, etc.), practitioners are often at a loss and management varies greatly from one centre to another.
Autosomal dominant polycystic kidney disease is characterised by the development of renal and hepatic cysts. While the main complication is chronic end-stage renal failure, specific cyst-related complications are common: intracystic haemorrhage, renal or hepatic cyst infections, cyst-related mechanical complications and lithiasis. To date, there is no reliable epidemiological data on the frequency and clinical impact of these complications. Diagnosis of these complications is often complicated, and their management has not been codified. The latest international recommendations (KDIGO) provide only low-level recommendations. For the most complex cases (recurrent cystic infections, resistant pain, mechanical complications and malnutrition, need for pre-transplant nephrectomy, etc.), practitioners are often at a loss and management varies greatly from one centre to another. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04039061 -
ADPKD Patient Registry
|
||
| Enrolling by invitation |
NCT05215964 -
The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease
|
||
| Recruiting |
NCT01680250 -
Sirolimus for Massive Polycystic Liver
|
Phase 2/Phase 3 | |
| Completed |
NCT00286156 -
Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
|
Phase 1/Phase 2 | |
| Terminated |
NCT01009957 -
Everolimus on CKD Progression in ADPKD Patients
|
Phase 2/Phase 3 | |
| Completed |
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|
||
| Completed |
NCT02739750 -
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
|
||
| Completed |
NCT03889392 -
Evaluation of Nephrectomy Specimen for Intracranial Aneurysm Development in ADPKD
|
||
| Completed |
NCT03948113 -
Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
|
||
| Recruiting |
NCT03726463 -
Evaluation of Iliac and Renal Artery for Mechanism of Intracranial Aneurysm in ADPKD
|
||
| Completed |
NCT03423810 -
Assessing a Dose‐Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients
|
Early Phase 1 |